PSYK ETF
Not enough financial coverage to compute a composite score for PSYK. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
The fund adviser uses a “passive management” (or indexing) approach to track the performance of the index. The index is a rules-based index that tracks the performance of a portfolio of companies that have business activity in the fields of psychedelic treatment used to address medical conditions in legal pharmacological applications under the applicable country’s laws. The fund will generally invest in all of the component securities of the index in the same approximate proportions as in the index.
- IPO
- 2022
- HQ
- DE, US
Price Chart
Performance & Tape
- 52W High
- $19.15
- 52W Low
- $16.10
- 50D MA
- $17.49
- 200D MA
- $17.56
- Beta
- 0.00
- Avg Volume
- 21.61K
Get TickerSpark's AI analysis on PSYK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PSYK Coverage
We haven't published any research on PSYK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PSYK Report →